Ispire Technology Inc. recently obtained ISO certifications for their manufacturing facility located in Malaysia.
In a recent press release (1), Ispire Technology Inc. (Ispire) and their subsidiary company, Ispire Malaysia Sdn Bhd, were granted three International Organization for Standardization (ISO) certifications for their manufacturing facility in Malaysia. The ISO certifications they received were the ISO9001: 2015 Quality Management System, ISO14001: 2015 Environmental Management System, and ISO13485: 2016 Quality Management System Medical Device certifications (1). Ispire’s Malaysian manufacturing facility is 31,000 sq ft. The vaping technology company is a leader in developing vaporized products and offers consumers a variety of items such as pod systems, disposables, cartridges, and batteries (1).
“Earning three ISO certifications at our Malaysian manufacturing facility is a testament to our team's ability to quickly bring the facility up to some of the highest standards in the industry, allowing us to expand our gross margins, geopolitically derisk our production and service other businesses who need manufacturing for their vape hardware,” Michael Wang, Ispire Technology Co-Chief Executive Officer, commented (1). “Currently, our Malaysian manufacturing facility has already received initial orders and is quickly moving into production readiness. As the facility ramps up production, our gross margin is expected to increase due to the lack of a tariff when assembling products in Malaysia and then shipping them to the U.S. This is in contrast to the 25% tariff incurred when shipping finished products from China. Additionally, by owning the factory, we also expect to be able to realize a profit on product assembly, which was formerly outsourced to a third party. We anticipate that these efficiency improvements will help drive gross-margin growth across the Company's full array of high-quality vaping products.”
As stated in their press release (1), ISO certifications are important for the manufacturing industry. These certifications will help Ispire’s facilities to “improve their processes, reduce errors and enhance product quality, leading to higher customer satisfaction,” (1). Ispire’s Malaysian facility will now be able to develop their resource utilization, better their operations, and lower waste.
Lastly, Wang added (1), Wang concluded, “We want to leverage third-party factories as well as our own manufacturing to ensure we have an uninterrupted global supply chain. Having our own factory infrastructure in Malaysia is expected to allow us to maximize gross margin on key high-volume products. By consistently delivering high-quality vaping products and services aligned with ISO standards, we expect that this will also increase customer satisfaction and loyalty, leading to repeat business and positive word-of-mouth recommendations.”
Reference
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.